Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1392

1.

Letter by Mente et al Regarding Article "Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease".

Mente A, O'Donnell MJ, Yusuf S.

Hypertension. 2019 Jun 24:HYPERTENSIONAHA11913321. doi: 10.1161/HYPERTENSIONAHA.119.13321. [Epub ahead of print] No abstract available.

PMID:
31230541
2.

Digoxin-mortality: randomized vs. observational comparison in the DIG trial.

Aguirre Dávila L, Weber K, Bavendiek U, Bauersachs J, Wittes J, Yusuf S, Koch A.

Eur Heart J. 2019 Jun 18. pii: ehz395. doi: 10.1093/eurheartj/ehz395. [Epub ahead of print]

PMID:
31211324
3.

Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.

Branch KR, Probstfield JL, Eikelboom JW, Bosch J, Maggioni AP, Cheng RK, Bhatt DL, Avezum A, Fox KAA, Connolly SJ, Shestakovska O, Yusuf S.

Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609. [Epub ahead of print]

PMID:
31163978
4.

Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.

Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD Jr, Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, den Hoed M, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jiménez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O'Donnell MJ, Psaty BM, Pulit SL, Rannikmäe K, Reiner AP, Rexrode KM, Rice K, Rich SS, Ridker PM, Rost NS, Rothwell PM, Rotter JI, Rundek T, Sacco RL, Sakaue S, Sale MM, Salomaa V, Sapkota BR, Schmidt R, Schmidt CO, Schminke U, Sharma P, Slowik A, Sudlow CLM, Tanislav C, Tatlisumak T, Taylor KD, Thijs VNS, Thorleifsson G, Thorsteinsdottir U, Tiedt S, Trompet S, Tzourio C, van Duijn CM, Walters M, Wareham NJ, Wassertheil-Smoller S, Wilson JG, Wiggins KL, Yang Q, Yusuf S; AFGen Consortium; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium; International Genomics of Blood Pressure (iGEN-BP) Consortium; INVENT Consortium; STARNET, Bis JC, Pastinen T, Ruusalepp A, Schadt EE, Koplev S, Björkegren JLM, Codoni V, Civelek M, Smith NL, Trégouët DA, Christophersen IE, Roselli C, Lubitz SA, Ellinor PT, Tai ES, Kooner JS, Kato N, He J, van der Harst P, Elliott P, Chambers JC, Takeuchi F, Johnson AD; BioBank Japan Cooperative Hospital Group; COMPASS Consortium; EPIC-CVD Consortium; EPIC-InterAct Consortium; International Stroke Genetics Consortium (ISGC); METASTROKE Consortium; Neurology Working Group of the CHARGE Consortium; NINDS Stroke Genetics Network (SiGN); UK Young Lacunar DNA Study; MEGASTROKE Consortium, Sanghera DK, Melander O, Jern C, Strbian D, Fernandez-Cadenas I, Longstreth WT Jr, Rolfs A, Hata J, Woo D, Rosand J, Pare G, Hopewell JC, Saleheen D, Stefansson K, Worrall BB, Kittner SJ, Seshadri S, Fornage M, Markus HS, Howson JMM, Kamatani Y, Debette S, Dichgans M.

Nat Genet. 2019 Jun 3. doi: 10.1038/s41588-019-0449-0. [Epub ahead of print]

PMID:
31160810
5.

Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS investigators.

Gastroenterology. 2019 May 29. pii: S0016-5085(19)40974-8. doi: 10.1053/j.gastro.2019.05.056. [Epub ahead of print]

PMID:
31152740
6.

Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent.

Cairns JA, Eikelboom JW, Shestakovska O, Yusuf S, DeMets D.

J Am Coll Cardiol. 2019 Jun 4;73(21):2769-2772. doi: 10.1016/j.jacc.2019.03.479. No abstract available.

PMID:
31146821
7.

Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial.

Fox KAA, Eikelboom JW, Shestakovska O, Connolly SJ, Metsarinne KP, Yusuf S.

J Am Coll Cardiol. 2019 May 14;73(18):2243-2250. doi: 10.1016/j.jacc.2019.02.048.

8.

Health Effects of Household Solid Fuel Use: Findings from 11 Countries within the Prospective Urban and Rural Epidemiology Study.

Hystad P, Duong M, Brauer M, Larkin A, Arku R, Kurmi OP, Fan WQ, Avezum A, Azam I, Chifamba J, Dans A, du Plessis JL, Gupta R, Kumar R, Lanas F, Liu Z, Lu Y, Lopez-Jaramillo P, Mony P, Mohan V, Mohan D, Nair S, Puoane T, Rahman O, Lap AT, Wang Y, Wei L, Yeates K, Rangarajan S, Teo K, Yusuf S; [on behalf of Prospective Urban and Rural Epidemiological (PURE) Study investigators].

Environ Health Perspect. 2019 May;127(5):57003. doi: 10.1289/EHP3915.

9.

Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A, Parkhomenko A, Ryden L, Pogosova N, Dans A, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne K, Fox KAA, Yusuf S; COMPASS investigators.

Gastroenterology. 2019 May 2. pii: S0016-5085(19)36764-2. doi: 10.1053/j.gastro.2019.04.041. [Epub ahead of print]

PMID:
31054846
10.

Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients.

Khunti K, Jung H, Dans AL, Held C, Dagenais GR, Yusuf S, Lonn E.

Can J Cardiol. 2019 May;35(5):644-652. doi: 10.1016/j.cjca.2019.03.002. Epub 2019 Mar 19.

PMID:
31030865
11.

Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study.

Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, Avezum A, Bengtsson Boström K, Chifamba J, Gulec S, Gupta R, Igumbor EU, Iqbal R, Ismail N, Joseph P, Kaur M, Khatib R, Kruger IM, Lamelas P, Lanas F, Lear SA, Li W, Wang C, Quiang D, Wang Y, Lopez-Jaramillo P, Mohammadifard N, Mohan V, Mony PK, Poirier P, Srilatha S, Szuba A, Teo K, Wielgosz A, Yeates KE, Yusoff K, Yusuf R, Yusufali AH, Attaei MW, McKee M, Yusuf S.

Lancet Glob Health. 2019 Jun;7(6):e748-e760. doi: 10.1016/S2214-109X(19)30045-2. Epub 2019 Apr 23.

12.

Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study.

Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, Rahman O, Yusoff K, du Plessis JL, Igumbor EU, Chifamba J, Li W, Lu Y, Zhi F, Yan R, Iqbal R, Ismail N, Zatonska K, Karsidag K, Rosengren A, Bahonar A, Yusufali A, Lamelas PM, Avezum A, Lopez-Jaramillo P, Lanas F, O'Byrne PM, Yusuf S; PURE investigators.

Lancet Glob Health. 2019 May;7(5):e613-e623. doi: 10.1016/S2214-109X(19)30070-1.

13.

Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countries.

Lamelas P, Diaz R, Orlandini A, Avezum A, Oliveira G, Mattos A, Lanas F, Seron P, Oliveros MJ, Lopez-Jaramillo P, Otero J, Camacho P, Miranda J, Bernabe-Ortiz A, Malaga G, Irazola V, Gutierrez L, Rubinstein A, Castellana N, Rangarajan S, Yusuf S.

J Hypertens. 2019 Apr 5. doi: 10.1097/HJH.0000000000002108. [Epub ahead of print]

PMID:
30964825
14.

Urinary sodium excretion measures and health outcomes - Authors' reply.

Mente A, O'Donnell MJ, Yusuf S.

Lancet. 2019 Mar 30;393(10178):1295-1296. doi: 10.1016/S0140-6736(19)30033-9. No abstract available. Erratum in: Lancet. 2019 Apr 20;393(10181):1596.

PMID:
30938310
15.

Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design.

Loeb M, Dokainish H, Dans A, Palileo-Villanueva LM, Roy A, Karaye K, Zhu J, Liang Y, Goma F, Damasceno A, AlHabib KF, Yonga G, Mondo C, Almahmeed W, Al Mulla A, Yusuf S; IVVE investigators.

Am Heart J. 2019 Jun;212:36-44. doi: 10.1016/j.ahj.2019.02.009. Epub 2019 Mar 11.

16.

Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2019 Mar 28. pii: ehz149. doi: 10.1093/eurheartj/ehz149. [Epub ahead of print]

PMID:
30919899
17.

An Infected Urachal Cyst in a 4-Year-Old Girl Presenting with Recurrent Abdominal Pain.

Yusuf S, Wassef AC, Schlesinger A.

J Emerg Med. 2019 Apr;56(4):e51-e54. doi: 10.1016/j.jemermed.2019.01.006. Epub 2019 Mar 14.

PMID:
30879848
18.

Recurrent Chest Wall and Axillary Lesions in a Teenage Boy.

Ayub EM, Bateman DW, Yusuf S.

J Emerg Med. 2019 Jun;56(6):715-716. doi: 10.1016/j.jemermed.2019.01.033. Epub 2019 Mar 14. No abstract available.

PMID:
30879845
19.

Prevention of Drowning.

Denny SA, Quan L, Gilchrist J, McCallin T, Shenoi R, Yusuf S, Hoffman B, Weiss J; COUNCIL ON INJURY, VIOLENCE, AND POISON PREVENTION.

Pediatrics. 2019 May;143(5). pii: e20190850. doi: 10.1542/peds.2019-0850. Epub 2019 Mar 15.

PMID:
30877146
20.

Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.

O'Donnell M, Mente A, Rangarajan S, McQueen MJ, O'Leary N, Yin L, Liu X, Swaminathan S, Khatib R, Rosengren A, Ferguson J, Smyth A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Ismail N, Yusoff K, Dans A, Iqbal R, Szuba A, Mohammadifard N, Oguz A, Yusufali AH, Alhabib KF, Kruger IM, Yusuf R, Chifamba J, Yeates K, Dagenais G, Wielgosz A, Lear SA, Teo K, Yusuf S; PURE Investigators.

BMJ. 2019 Mar 13;364:l772. doi: 10.1136/bmj.l772.

21.

Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial.

Alak A, Hohnloser SH, Fräßdorf M, Reilly P, Ezekowitz M, Healey JS, Brueckmann M, Yusuf S, Connolly SJ.

Europace. 2019 Mar 8. pii: euz021. doi: 10.1093/europace/euz021. [Epub ahead of print]

PMID:
30848783
22.

Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial.

Garg AX, Chan MTV, Cuerden MS, Devereaux PJ, Abbasi SH, Hildebrand A, Lamontagne F, Lamy A, Noiseux N, Parikh CR, Perkovic V, Quantz M, Rochon A, Royse A, Sessler DI, Shah PJ, Sontrop JM, Tagarakis GI, Teoh KH, Vincent J, Walsh M, Yared JP, Yusuf S, Whitlock RP; SIRS Investigators.

CMAJ. 2019 Mar 4;191(9):E247-E256. doi: 10.1503/cmaj.181644.

23.

Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study.

Bosch J, O'Donnell M, Swaminathan B, Lonn EM, Sharma M, Dagenais G, Diaz R, Khunti K, Lewis BS, Avezum A, Held C, Keltai M, Reid C, Toff WD, Dans A, Leiter LA, Sliwa K, Lee SF, Pogue JM, Hart R, Yusuf S; HOPE-3 Investigators.

Neurology. 2019 Mar 26;92(13):e1435-e1446. doi: 10.1212/WNL.0000000000007174. Epub 2019 Feb 27.

PMID:
30814321
24.

Effects of basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial.

Dagenais GR, Jung H, Bogaty P, Bosch J, Yusuf S, Gerstein HC.

Diabetes Obes Metab. 2019 Jun;21(6):1502-1505. doi: 10.1111/dom.13674. Epub 2019 Mar 20.

PMID:
30785660
25.

Imaging of Pancreatic-Neuroendocrine Tumours: an Outline of Conventional Radiological Techniques.

Zamir MA, Hakim W, Yusuf S, Thomas R.

Curr Radiopharm. 2019 Feb 14. doi: 10.2174/1874471012666190214165845. [Epub ahead of print]

PMID:
30767758
26.

Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors.

Palaskas N, Morgan J, Daigle T, Banchs J, Durand JB, Hong D, Naing A, Le H, Hassan SA, Karimzad K, Mouhayar E, Kim P, Lopez-Mattei J, Thompson K, Yusuf SW, Iliescu C.

Am J Cardiol. 2019 Apr 15;123(8):1351-1357. doi: 10.1016/j.amjcard.2019.01.013. Epub 2019 Jan 25.

PMID:
30765065
27.

Peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours.

Alsadik S, Yusuf S, Al-Nahhas A.

Curr Radiopharm. 2019 Feb 1. doi: 10.2174/1874471012666190201164132. [Epub ahead of print]

PMID:
30714538
28.

Stroke Outcomes in the COMPASS Trial.

Sharma M, Hart RG, Connolly SJ, Bosch J, Shestakovska O, Ng KKH, Catanese L, Keltai K, Aboyans V, Alings M, Ha JW, Varigos J, Tonkin A, O'Donnell M, Bhatt DL, Fox K, Maggioni A, Berkowitz SD, Bruns NC, Yusuf S, Eikelboom JW.

Circulation. 2019 Feb 26;139(9):1134-1145. doi: 10.1161/CIRCULATIONAHA.118.035864.

PMID:
30667279
29.

Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups.

Paré G, Çaku A, McQueen M, Anand SS, Enas E, Clarke R, Boffa MB, Koschinsky M, Wang X, Yusuf S; INTERHEART Investigators.

Circulation. 2019 Mar 19;139(12):1472-1482. doi: 10.1161/CIRCULATIONAHA.118.034311.

PMID:
30667276
30.

The MANAGE trial - Authors' reply.

Devereaux PJ, Duceppe E, Guyatt G, Balasubramanian K, Yusuf S.

Lancet. 2019 Jan 19;393(10168):228. doi: 10.1016/S0140-6736(19)30078-9. No abstract available.

PMID:
30663594
31.

The cost implication of primary prevention in the HOPE 3 trial.

Lamy A, Lonn E, Tong W, Swaminathan B, Jung H, Gafni A, Bosch J, Yusuf S.

Eur Heart J Qual Care Clin Outcomes. 2019 Jan 17. doi: 10.1093/ehjqcco/qcz001. [Epub ahead of print]

PMID:
30657891
32.

Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.

Lamy A, Eikelboom J, Sheth T, Connolly S, Bosch J, Fox KAA, Zhu J, Lonn E, Dagenais G, Widimsky P, Branch KRH, Bhatt DL, Zheng Z, Straka Z, Dagenais F, Kong Y, Marsden T, Lee SF, Copland I, Yusuf S.

J Am Coll Cardiol. 2019 Jan 22;73(2):121-130. doi: 10.1016/j.jacc.2018.10.048.

PMID:
30654882
33.

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the  RE - LY Trial.

Hijazi Z, Verdecchia P, Oldgren J, Andersson U, Reboldi G, Di Pasquale G, Mazzotta G, Angeli F, Eikelboom JW, Ezekowitz MD, Connolly SJ, Yusuf S, Wallentin L.

J Am Heart Assoc. 2019 Jan 22;8(2):e010107. doi: 10.1161/JAHA.118.010107.

34.

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2018 Dec 24. doi: 10.1093/eurheartj/ehy808. [Epub ahead of print]

PMID:
30590564
35.

Cardiovascular manifestations of Erdheim-Chester disease.

Ghotra AS, Thompson K, Lopez-Mattei J, Bawa D, Hernandez R, Banchs J, Palaskas N, Iliescu C, Kim P, Yusuf SW, Hassan SA.

Echocardiography. 2019 Feb;36(2):229-236. doi: 10.1111/echo.14231. Epub 2018 Dec 20.

PMID:
30569522
36.

Frequency of Takotsubo Cardiomyopathy in Adult Patients Receiving Chemotherapy (from a 5-Year Nationwide Inpatient Study).

Desai R, Abbas SA, Goyal H, Durairaj A, Fong HK, Hung O, Sachdeva R, Barac A, Yusuf SW, Kumar G.

Am J Cardiol. 2019 Feb 15;123(4):667-673. doi: 10.1016/j.amjcard.2018.11.006. Epub 2018 Nov 24.

PMID:
30538037
37.

Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study.

Pais P, Jung H, Dans A, Zhu J, Liu L, Kamath D, Bosch J, Lonn E, Yusuf S.

Eur J Prev Cardiol. 2019 May;26(7):681-697. doi: 10.1177/2047487318819019. Epub 2018 Dec 11.

PMID:
30537846
38.

Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries.

Wang C, Bangdiwala SI, Rangarajan S, Lear SA, AlHabib KF, Mohan V, Teo K, Poirier P, Tse LA, Liu Z, Rosengren A, Kumar R, Lopez-Jaramillo P, Yusoff K, Monsef N, Krishnapillai V, Ismail N, Seron P, Dans AL, Kruger L, Yeates K, Leach L, Yusuf R, Orlandini A, Wolyniec M, Bahonar A, Mohan I, Khatib R, Temizhan A, Li W, Yusuf S.

Eur Heart J. 2019 May 21;40(20):1620-1629. doi: 10.1093/eurheartj/ehy695.

PMID:
30517670
39.

Metamagnetism in Nanosheets of CoII-MOF with TN at 26 K and a Giant Hysteretic Effect at 5 K.

Gupta K, Dadwal A, Rana S, Jha PK, Jain A, Yusuf SM, Joy PA, Ballav N.

Inorg Chem. 2018 Dec 17;57(24):15044-15047. doi: 10.1021/acs.inorgchem.8b03064. Epub 2018 Dec 4.

PMID:
30511846
40.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration.

J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994.

PMID:
30499920
41.

The spectrum of the dyslipidemia in Colombia: The PURE study.

Camacho PA, Otero J, Pérez M, Arcos E, García H, Narvaez C, Molina DI, Sanchez G, Duran M, Cure C, Sotomayor A, Rico Á, Cotes F, Rangarajan S, Yusuf S, Cohen DD, González-Gómez S, Clausen C, Lopez-Jaramillo P.

Int J Cardiol. 2019 Jun 1;284:111-117. doi: 10.1016/j.ijcard.2018.10.090. Epub 2018 Nov 5.

PMID:
30463681
42.

Effects of Trypanocidal Treatment on Echocardiographic Parameters in Chagas Cardiomyopathy and Prognostic Value of Wall Motion Score Index: A BENEFIT Trial Echocardiographic Substudy.

Schmidt A, Dias Romano MM, Marin-Neto JA, Rao-Melacini P, Rassi A Jr, Mattos A, Avezum Á Jr, Villena E, Sosa-Estani S, Bonilla R, Yusuf S, Morillo CA, Maciel BC; BENEFIT Investigators.

J Am Soc Echocardiogr. 2019 Feb;32(2):286-295.e3. doi: 10.1016/j.echo.2018.09.006. Epub 2018 Nov 9.

PMID:
30420161
43.

Ten-Year-Old Girl with Spontaneous Passage of Multiple Magnetic Foreign Bodies.

Hyde CR, Yusuf S.

J Paediatr Child Health. 2018 Nov;54(11):1278-1279. doi: 10.1111/jpc.14159. No abstract available.

PMID:
30387263
44.

The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct.

Joseph P, Pais P, Dans AL, Bosch J, Xavier D, Lopez-Jaramillo P, Yusoff K, Santoso A, Talukder S, Gamra H, Yeates K, Lopez PC, Tyrwhitt J, Gao P, Teo K, Yusuf S; TIPS-3 Investigators.

Am Heart J. 2018 Dec;206:72-79. doi: 10.1016/j.ahj.2018.07.012. Epub 2018 Aug 2.

45.

Enhancement of simultaneous batik wastewater treatment and electricity generation in photocatalytic fuel cell.

Khalik WF, Ho LN, Ong SA, Voon CH, Wong YS, Yusuf SY, Yusoff NA, Lee SL.

Environ Sci Pollut Res Int. 2018 Dec;25(35):35164-35175. doi: 10.1007/s11356-018-3414-z. Epub 2018 Oct 17.

PMID:
30328543
46.

Contracting-out urban primary health care in Bangladesh: a qualitative exploration of implementation processes and experience.

Islam R, Hossain S, Bashar F, Khan SM, Sikder AAS, Yusuf SS, Adams AM.

Int J Equity Health. 2018 Oct 5;17(1):93. doi: 10.1186/s12939-018-0805-1.

47.

Methanolic leaf extract of Moringa oleifera improves the survivability rate, weight gain and histopathological changes of Wister rats infected with Trypanosoma brucei.

Aremu A, Kingsley EI, Talha BK, Akeem AO, Ibrahim RA, Jimoh AG, Yusuf SK.

Int J Vet Sci Med. 2018 Jun 14;6(1):39-44. doi: 10.1016/j.ijvsm.2018.04.006. eCollection 2018 Jun.

48.

Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study.

Dehghan M, Mente A, Rangarajan S, Sheridan P, Mohan V, Iqbal R, Gupta R, Lear S, Wentzel-Viljoen E, Avezum A, Lopez-Jaramillo P, Mony P, Varma RP, Kumar R, Chifamba J, Alhabib KF, Mohammadifard N, Oguz A, Lanas F, Rozanska D, Bostrom KB, Yusoff K, Tsolkile LP, Dans A, Yusufali A, Orlandini A, Poirier P, Khatib R, Hu B, Wei L, Yin L, Deeraili A, Yeates K, Yusuf R, Ismail N, Mozaffarian D, Teo K, Anand SS, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study investigators.

Lancet. 2018 Nov 24;392(10161):2288-2297. doi: 10.1016/S0140-6736(18)31812-9. Epub 2018 Sep 11.

PMID:
30217460
49.

Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.

Karthikeyan G, Devasenapathy N, Zühlke L, Engel ME, Rangarajan S, Teo KK, Mayosi BM, Yusuf S; Global Rheumatic Heart Disease Registry (REMEDY) Investigators.

Heart. 2018 Sep 12. pii: heartjnl-2018-313614. doi: 10.1136/heartjnl-2018-313614. [Epub ahead of print]

PMID:
30209123
50.

Bongani Mayosi, a hero remembered.

Ntsekhe M, Commerford P, Brink P, Yusuf S.

Cardiovasc J Afr. 2018 Jul/Aug;29(4):206. No abstract available.

Supplemental Content

Support Center